- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 47/10 - Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
Patent holdings for IPC class A61K 47/10
Total number of patents in this class: 10959
10-year publication summary
|
864
|
950
|
1071
|
1165
|
1291
|
1257
|
1405
|
1322
|
1222
|
371
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Allergan, Inc. | 2600 |
74 |
| Hisamitsu Pharmaceutical Co., Inc. | 792 |
67 |
| FUJIFILM Corporation | 27102 |
54 |
| Coherus Biosciences, Inc. | 172 |
50 |
| Camurus AB | 153 |
47 |
| Novartis AG | 11238 |
46 |
| Infirst Healthcare Limited | 60 |
43 |
| The Procter & Gamble Company | 22178 |
42 |
| Rohto Pharmaceutical Co., Ltd. | 349 |
42 |
| Eagle Pharmaceuticals, Inc. | 101 |
41 |
| Kobayashi Pharmaceutical Co., Ltd. | 829 |
41 |
| Santen Pharmaceutical Co., Ltd. | 649 |
40 |
| LTS Lohmann Therapie-Systeme AG | 691 |
39 |
| Arcutis Biotherapeutics, Inc. | 81 |
38 |
| Novo Nordisk A/S | 2324 |
37 |
| GW Research Limited | 402 |
36 |
| Bausch Health Ireland Limited | 751 |
36 |
| Takeda Pharmaceutical Company Limited | 2961 |
35 |
| Yissum Research Development Company of The Hebrew University of Jerusalem Ltd. | 1338 |
35 |
| Massachusetts Institute of Technology | 9795 |
34 |
| Other owners | 10082 |